X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (21) 21
index medicus (17) 17
hypertension (16) 16
female (11) 11
pharmacology & pharmacy (11) 11
male (10) 10
cardiac & cardiovascular systems (9) 9
cardiology (9) 9
hypertension - drug therapy (9) 9
medicine, general & internal (9) 9
middle aged (9) 9
blood pressure - drug effects (8) 8
medicine & public health (8) 8
pharmacology/toxicology (8) 8
risk factors (8) 8
aged (7) 7
antihypertensive agents - therapeutic use (7) 7
cardiovascular events (6) 6
care and treatment (6) 6
drug therapy, combination (6) 6
mortality (6) 6
prasugrel (6) 6
acute coronary syndrome (5) 5
adult (5) 5
cardiology and cardiovascular medicine (5) 5
cardiovascular diseases (5) 5
drug therapy (5) 5
internal medicine (5) 5
medicine, research & experimental (5) 5
percutaneous coronary intervention (5) 5
pharmacology (5) 5
review (5) 5
review article (5) 5
stroke (5) 5
treatment outcome (5) 5
analysis (4) 4
angiotensin-converting enzyme inhibitors - therapeutic use (4) 4
chronic heart-failure (4) 4
clopidogrel (4) 4
dosage and administration (4) 4
drug combinations (4) 4
endocrinology (4) 4
guidelines (4) 4
indapamide (4) 4
intervention (4) 4
myocardial infarction (4) 4
oncology (4) 4
perindopril (4) 4
pharmacotherapy (4) 4
renin-angiotensin system - drug effects (4) 4
rheumatology (4) 4
therapy (4) 4
trial (4) 4
abridged index medicus (3) 3
acute myocardial-infarction (3) 3
adherence (3) 3
amlodipine (3) 3
angiotensin (3) 3
angiotensin receptor antagonists - therapeutic use (3) 3
animals (3) 3
anticoagulants (3) 3
atherosclerosis (3) 3
blood platelets (3) 3
blood-pressure (3) 3
cardiac patients (3) 3
coronary heart disease (3) 3
diabetes mellitus (3) 3
health technology assessment (3) 3
hemorrhage - chemically induced (3) 3
high-risk patients (3) 3
hungary (3) 3
hypertension - etiology (3) 3
hypertension - physiopathology (3) 3
management (3) 3
outcomes (3) 3
platelet aggregation inhibitors - administration & dosage (3) 3
platelet aggregation inhibitors - adverse effects (3) 3
platelets (3) 3
prospective studies (3) 3
research (3) 3
ticagrelor (3) 3
ticlopidine - analogs & derivatives (3) 3
acalculous cholecystitis (2) 2
ace inhibitors (2) 2
ace-inhibition (2) 2
acute coronary syndrome - complications (2) 2
acute coronary syndrome - therapy (2) 2
acute coronary syndromes (2) 2
adrenergic beta-antagonists - therapeutic use (2) 2
american-college (2) 2
amlodipine - therapeutic use (2) 2
angiotensin ii type 1 receptor blockers - therapeutic use (2) 2
angiotensin-converting enzyme inhibitors (2) 2
antihypertensive agents - administration & dosage (2) 2
antihypertensive agents - pharmacology (2) 2
antiplatelet therapy (2) 2
atrial-fibrillation (2) 2
blood pressure (2) 2
blood pressure monitoring, ambulatory - methods (2) 2
calcium channel blocker (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of International Medical Research, ISSN 0300-0605, 5/2018, Volume 46, Issue 5, pp. 1902 - 1909
Background In patients with stable coronary artery disease, aspirin, a statin, and an angiotensin-converting enzyme inhibitor are recommended as first-line... 
Stable coronary artery disease | statin | adherence | angiotensin-converting enzyme inhibitor | calcium channel blocker | hypertension | hypercholesterolemia | MEDICINE, RESEARCH & EXPERIMENTAL | IMPACT | THERAPY | EFFICACY | PHARMACOLOGY & PHARMACY | Clinical Reports
Journal Article
American Journal of Cardiovascular Drugs, ISSN 1175-3277, 10/2017, Volume 17, Issue 5, pp. 361 - 373
According to new hypertension guidelines [2], bblockers have been forced into the second line of therapeutic recommendations for essential hypertension, behind... 
Studies | Cardiac arrhythmia | Mortality | Chronic obstructive pulmonary disease | Health risk assessment
Journal Article
by Sibbing, Dirk and Aradi, Dániel and Aradi, Daniel and Jacobshagen, Claudius and Gross, Lisa and Trenk, Dietmar and Geisler, Tobias and Orban, Matthias and Orban, Martin and Hadamitzky, Martin and Merkely, Béla and Kiss, Róbert Gábor and Komócsi, András and Dézsi, Csaba A and Dézsi, Csaba András and Dézsi, András Döme and Holdt, Lesca and Felix, Stephan and Felix, Stephan B and Parma, Zofia and Parma, Radoslaw and Klopotowski, Mariusz and Schwinger, Robert and Schwinger, Robert H G and Rieber, Johannes and Huber, Kurt and Neumann, Franz-Josef and Koltowski, Lukasz and Mehilli, Julinda and Huczek, Zenon and Massberg, Steffen and Lesiak, Maciej and Komosa, Anna and Kowara, Michal and Rymuza, Bartosz and Malek, Lukasz and Veress, Gábor and Lux, Árpád and Papp, Judit and Kovács, Andrea and Amer, Sayour and Ruzsa, Zoltán and Róna, Szilárd and Ili, Renáta and Ungi, Imre and Nagy, Ferenc and Zweiker, Robert and Tóth-Gayor, Gábor and Haller, Paul and von Scheidt, Wolfgang and Blüthgen, Andreas and Leggewie, Stefan and Kreider-Stempfle, Hans Ulrich and Remp, Thomas and Kara, Kaffer and Mügge, Andreas and Wutzler, Alexander and Fichtlscherer, Stephan and Zeiher, Andreas M and Seeger, Florian and Hinterseer, Martin and König, Andreas and Lederle, Susanne and Czepluch, Frauke and Maier, Lars and Schillinger, Wolfgang and Sossalla, Samuel and Hummel, Astrid and Karakas, Mahir and Sydow, Karsten and Rudolph, Tanja and Halbach, Marcel and Gori, Tommaso and Münzel, Thomas and May, Andreas and Gerstenberg, Carsten-Manuel and Pilecky, David and Deichstetter, Markus and Kääb, Stefan and Löw, Anja and Sattler, Stefan and Deuschl, Sabine and Teupser, Daniel and Mudra, Harald and Räder, Thomas and Schütz, Torsten and Vahldiek, Felix and Divchev, Dimitar and Ince, Hüseyin and Nienaber, Christoph A and Radunski, Henning and Boekstegers, Peter and Horstkotte, Jan and Mueller, Ralf and Müller, Karin and Rasp, Oliver and TROPICAL-ACS Investigators
The Lancet, ISSN 0140-6736, 10/2017, Volume 390, Issue 10104, pp. 1747 - 1757
Current guidelines recommend potent platelet inhibition with prasugrel or ticagrelor for 12 months after an acute coronary syndrome managed with percutaneous... 
ELUTING STENTS | MEDICINE, GENERAL & INTERNAL | CLOPIDOGREL | THERAPY | TICAGRELOR | TREATMENT PATTERNS | ACADEMIC RESEARCH CONSORTIUM | PRASUGREL | DIPHOSPHATE RECEPTOR INHIBITOR | MYOCARDIAL-INFARCTION PATIENTS | PLATELET REACTIVITY | Myocardial Infarction - epidemiology | Acute Coronary Syndrome - epidemiology | Drug Administration Schedule | Hemorrhage - epidemiology | Humans | Middle Aged | Europe - epidemiology | Male | Prasugrel Hydrochloride - adverse effects | Ticlopidine - analogs & derivatives | Platelet Aggregation Inhibitors - administration & dosage | Platelet Function Tests | Ticlopidine - adverse effects | Ticlopidine - administration & dosage | Acute Coronary Syndrome - therapy | Clopidogrel | Female | Stroke - epidemiology | Hemorrhage - chemically induced | Prasugrel Hydrochloride - administration & dosage | Drug Monitoring | Percutaneous Coronary Intervention | Platelet Aggregation Inhibitors - adverse effects | Transluminal angioplasty | Care and treatment | Coronary heart disease | Cardiac patients | Analysis | Anticoagulants | Heart attacks | Blood platelets | Angioplasty | Clinical trials | Acute coronary syndromes | Drug therapy | Patients | Clinical outcomes | Myocardial infarction | Intervention | Medical services | Bleeding | Consortia | Randomization | Motivation | Bioindicators | Inhibition | Cerebral infarction | Stroke | Test procedures | Health risks | Thrombosis | Coronary vessels | Biomarkers | Infarction | Cardiovascular diseases | Platelets
Journal Article
Orvosi Hetilap, ISSN 0030-6002, 02/2014, Volume 155, Issue 7, pp. 263 - 269
Journal Article
Orvosi hetilap, 03/2019, Volume 160, Issue 10, p. 370
The European Union (EU) law harmonization expects from each EU country to apply the same principles and same standards of the medical evaluation of driving... 
Journal Article
Journal Article
American Journal of Cardiovascular Drugs, ISSN 1175-3277, 10/2017, Volume 17, Issue 5, pp. 361 - 373
Journal Article
Journal of Hypertension, ISSN 0263-6352, 10/2018, Volume 36 Suppl 3, pp. e202 - e202
OBJECTIVES:To assess the effectiveness of perindopril/indapamide (P/I) single-pill combination by combined analysis of 4 studies in patients with uncontrolled... 
Hypertension | Development and progression | Dosage and administration | Indapamide | Drug therapy
Journal Article
Journal of Hypertension, ISSN 0263-6352, 10/2018, Volume 36 Suppl 3, pp. e202 - e202
OBJECTIVES:To assess effectiveness of perindopril/indapamide (P/I) single-pill combination at full dose in everyday practice in obese patients with... 
Hypertension | Dosage and administration | Indapamide | Drug therapy
Journal Article
Journal of Hypertension, ISSN 0263-6352, 10/2018, Volume 36 Suppl 3, pp. e203 - e203
OBJECTIVES:To assess effectiveness of perindopril/indapamide (P/I) single-pill combination at full dose in patients with uncontrolled hypertension (HT) with... 
Hypertension | Diuresis | Indapamide | Patient outcomes | Physiological aspects | Diabetes | Drug therapy | Health aspects
Journal Article